Nathalie Adda
2018
In 2018, Nathalie Adda earned a total compensation of $1.5M as Senior Vice President, Chief Medical Officer at Enanta Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,670 |
|---|---|
| Option Awards | $630,855 |
| Salary | $421,425 |
| Stock Awards | $275,275 |
| Other | $18,851 |
| Total | $1,514,076 |
Adda received $630.9K in option awards, accounting for 42% of the total pay in 2018.
Adda also received $167.7K in non-equity incentive plan, $421.4K in salary, $275.3K in stock awards and $18.9K in other compensation.
Rankings
In 2018, Nathalie Adda's compensation ranked 7,110th out of 14,244 executives tracked by ExecPay. In other words, Adda earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,110 out of 14,244 | 50th |
Division Manufacturing | 2,736 out of 5,765 | 53rd |
Major group Chemicals And Allied Products | 1,032 out of 2,128 | 52nd |
Industry group Drugs | 871 out of 1,817 | 52nd |
Industry Pharmaceutical Preparations | 680 out of 1,391 | 51st |
Source: SEC filing on January 18, 2019.
Adda's colleagues
We found four more compensation records of executives who worked with Nathalie Adda at Enanta Pharmaceuticals in 2018.